Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.


TSXV:RX - Post by User

Bullboard Posts
Post by mcv1on Jul 10, 2013 12:08am
524 Views
Post# 21598005

RX completed a reverse head and shoulders - very bullish pattern

RX completed a reverse head and shoulders - very bullish patternLeft shoulder mid Feb to mid March. Head from mid March to early June.  Right shoulder from early June to early July.  The breakout to a new high this month on volume confirms the trend.  We should be good to at least $2 to $2.60 minimum.

For those who want a GREAT value play with huge EPS and sales growth and tight share float check out iPlayco IPC.V.  Expecting strong growth in EPS next 2Qs and beyond.  Earnings are coming out early August if you like it better to buy now BEFORE the news is out.  This company has fewer shares than RX.

                                   RX               IPC
Share Price                1.64              0.60
EPS                              .11                .08
Share count                13.57M        10.22M

Do your own due dilgence but don't wait too long.

mcv
Bullboard Posts